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1. Introduction 
Cyclic AMP production in gastric epithelium is 
regulated by numerous substances. In the different 
species studied, histamine stimulated the production 
of cyclic AMP only in the fundic part of gastric 
epithelium ( [ 1,2], C.G. et al., in preparation). This 
effect was shown to be related to the regulation by 
histamine of the acid secretion by parietal cells [3,4]. 
In the other cells of the stomach, namely the pep- 
sinogen and mucous-secreting cells, which occur both 
in fundus and in antrum [5], secretin was described as 
the sole peptide stimulating cyclic AMP production at 
low physiological doses ([4], C.G. et al., in prepara- 
tion). When a stimulating effect of vasoactive intesti- 
nal peptide (VIP) was found, concentrations of VIP 
200-times higher were needed to exert the same effect 
as secretin (C.G. et al., in preparation), strongly sug- 
gesting that VIP, a natural analog of secretin was a 
positive agonist of this peptide. 
This study was carried out in humans, using an 
original preparation of pure gastric epithelial glands. 
We demonstrate that in the human, the peptide 
stimulating at physiological doses the cyclic AMP 
system of gastric epithelium is not secretin but VIP, 
that acted at as low as lo-” M both in fundus and in 
antrum epithelial glands. 
2. Materials and methods 
2.1. Preparation of human gastric epithelial glands 
Sections (10 cm”) of the healthy fundic and antral 
parts of the stomach were obtained during subtotal 
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gastrectomy for cancer. It was verified that none of 
the patients underwent any treatment by histamine 
Hz receptor blocking agent. The fragment was sewed 
in order to make a sac exposing mucosa. Mucous was 
removed with absorbant paper. Epithelial cells were 
isolated and harvested using an EDTA procedure, as 
described for the isolation of human colonic epi- 
thelial crypts [6] . Glands were rinsed and resuspended 
in Krebs-Ringer phosphate (pH 7.5). Microscope 
examination showed entire gastric epithelial glands, 
keeping their structure after separation from the 
Zamina propria. Single cells were scarce. We verified 
that the preparation was not contaminated by cells 
from blood or from the connective tissue of the sub- 
mucosal layer. DNA [7] and proteins [8] were 
measured: 1 mg DNA corresponding to 56.26 f 13.95 
mg protein (n = 10). 
2.2. Extraction and measurement of VIP 
Extraction and assay of VIP from the cellular 
preparation and from the whole thickness fragments 
of stomach were done as in [6,9]. 
2.3. Measurement of cyclic AMP accumulation 
Unless otherwise mentioned, in a standard assay, 
cells (-2-4 pg DNA/ml) were incubated under con- 
tinuous agitation at 150 osc./min in a shaking bath 
(SB4, Techne, Duxford, Cambridge) for 30 min at 
37°C in 0.5 ml Krebs-Ringer phosphate, containing 
1.4% bovine serum albumin (w/v), 0.5 mM 3-isobutyl- 
1-methylxanthine (iBuMeXan) (pH 7.5). Cells were 
preincubated for 10 min before addition of effecters. 
The incubation was stopped by adding 50 ~1 11 N 
HCl&. After centrifugation for 10 min at 4000 X g 
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the cyclic AMP present in the supernatant was 
succinylated and measured by radioimmunoassay as 
in (61. 
2.4. Pep tides and reagents 
Highly purified porcine VIP was generously sup- 
plied by V. Mutt (GIH Laboratory, Stockholm) 
through the Gastrointestinal Hormones Resources 
Committee of the National Institute of Arthritis, 
Metabolism and Digestive Diseases (USA) and syn- 
thetic porcine secretin by E. Wunsch (Max Planck 
Institute, Munich). Porcine pancreatic glucagon was 
purchased from Novo Research Inst. (Copenhagen), 
bovine serum albumin (fraction V) from Miles Labs. 
(Elkhart, IN), calf thymus DNA from Sigma Chemical 
Co. (St Louis, MO). Other chemicals and biochem- 
icals, all of highest purity grade, were purchased from 
standard suppliers. 
3. Results 
3 .l . VIP concentrations in human stomach 
VIP concentrations in fragments of human gastric 
fundus and antrum amounted to 607 + 214 rig/g tissue 
wet wt (mean + SEM, n = 3), and compared well with 
those in [IO]. No VIP was found in gastric epithelial 
glands indicating that the VIP measured in gastric 
fragments was confined to the submucosal and the 
muscular layers of the stomach. 
3.2. Stimulation of cyclic AMPproduction in human 
gastric epithelialglands by peptides and histamine 
VIP (1 O-’ M) increased cyclic AMP levels in all 
conditions tested (fig.1). In the absence of phos- 
phodiesterase inhibitor, the maximal rise in a prepara- 
tion of fundus epithelial glands represented 2 f 0.02- 
times the basal level 0, < 0.05) and was followed by a 
gradual decrease. In the presence of phosphodiesterase 
inhibitor, the effect of VIP was potentiated and 
remained stable from 30-90 min incubation. The % 
of increase above basal of the VIP-induced cyclic 
AMP rise was maximal in the presence of 0.5 mM 
iBuMeXan (fig.1). 
The effect of different concentrations of VIP in 
promoting a cyclic AMP rise in fundus and antrum 
gastric epithelial glands was studied in optimal con- 
ditions (fig.2). VIP induced a significant cyclic AMP 
riseatas1owas10-“M(p<0.05andp<0.01in 
fundus and antrum, respectively); maximal stimula- 
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Fig.1. Stimulation by VIP of cyclic AMP accumulation in 
epithelial glands isolated from human gastric fundus. Epi- 
thelial glands (3 /lg DNA/ml) were incubated at 37°C in the 
presence of the indicated concentrations of phosphodiesterase 
inhibitor iBuMeXan as otherwise in section 2. Reaction was 
started after a 10 mm preincubation by addition of VIP and 
was stopped at the indicated time by addition of 11 N HClO,. 
Values are mean of a single experiment performed in tripli- 
cate, 2 other experiments gave similar results. 
011 10 9 8 7 6 5 4 3011 10 9 8 7 6 5 4 3 
-log [eKector],M 
Fig.2. Cyclic AMP production in epithelial glands isolated 
from fundus and antrum from the same human stomach in 
response to increasing concentrations of VIP, secretin and 
histamine. Cells (2.3 fig DNA/ml) were incubated 30 min at 
37°C in the presence of 0.5 mM iBuMeXan. Reaction was 
started after a 10 min preincubation by addition of the 
effector and was stopped by addition of 11 N HClO,. The 
experiment was performed in triplicate, 2 other experiments 
gave similar results. 
Volume 113, number 1 FEBS LETTERS April 1980 
Table 1 
Cyclic AMP production in human gastric epithelial crypts in response to VIP 
and histamine 
Cyclic AMP production (% basal) 
Fundus Antrum 
Basal 100 100 
VIP lo-’ M 450 i 140 1770 + 550a 
Histamine 10m3 M 560 * 140 123+ 13a 
VIP lo-* M + histamine 10e3 M 1125 f 190 1750 f 460 
a p < 0.05 for difference between results observed in fundus and antrum 
Values are means * SEM of values obtained in 5 different stomachs. Each experi- 
ment was done in triplicate. Basal level of cyclic AMP was 1.36 f 0.24 and 1.26 + 
0.36 pmol cyclic AMP/pg DNA in fundus and antrum, respectively 
tion of cyclic AMP production was observed at lo-* 
M VIP, half-maximal stimulation being observed at 
3 X lo-” M VIP. As indicated in table 1, the % of 
increase above basal of the VIP-induced cyclic AMP 
rise was significantly lower in fundus where parietal 
cells account for 30% of the total cell population 
[ 111 otherwise composed of mucous cells and chief 
cells, than in antrum composed mainly of mucous 
and pepsinogen-containing cells [ 51. 
Secretin was also able to stimulate cyclic AMP 
formation in human gastric epithelium (fig.2). How- 
ever, the potency of secretin remained 1 04-times 
lower than that of VIP since a significant cyclic AMP 
rise was observed only at 3 X 10v7 M and lo-’ M in 
fundic and antral epithelial glands, respectively @ < 
0.05). Addition of lo-‘M VIP together with 5 X 
10 -6 M secretin elicited no additive effect (not shown) 
Histamine determined a cyclic AMP rise only in 
epithelial glands isolated from fundus (fig.2), being 
ineffective in antrum. These data, in agreement with 
observations of adenylate cyclase activities in human 
biopsy specimen [2,12,13], indicate that the hista- 
mine-sensitive cyclic AMP system is present only in 
the fundic part of the human stomach, where parietal 
cells are localized. Incubation of maximally active 
concentrations of VIP (lo-’ M) together with hista- 
mine (10e3 M) showed that their effect on cyclic 
AMP accumulation in human fundic epithelial glands 
were additive (table 1). 
4. Discussion 
Our data demonstrate that, in human, gastric epi- 
thelial glands isolated from fundus and antrum express 
a cyclic AMP system highly sensitive to VIP. Indeed, 
VIP was used in a range of concentrations (lo-“- 
lo-* M) that was 104-times lower than that reported 
to activate adenylate cyclase activity in homogenates 
of human gastric mucosa [ 141. Secretin was consider- 
ably less potent than VIP in stimulating cyclic AMP 
production in human gastric epithelial glands and 
presumably acted only through the VIP-sensitive 
cyclic AMP system as shown by the absence of addi- 
tive effect of VIP and secretin. 
Comparison of the effects of VIP and secretin on 
cyclic AMP accumulation in gastric epithelium evi- 
dences a narrow species specificity: in epithelial cells 
isolated from dog fundus and in epithelial glands 
prepared from rat fundus and antrum, secretin stim- 
ulated cyclic AMP production at 10-9-10-10 M; 
furthermore concentrations of VIP 200-times higher 
than those of secretin were needed to achieve the 
same stimulating effect on cyclic AMP production 
in rat gastric epithelial glands (C.G. et al., in prepara- 
tion). Thus, the sensitivity of cyclic AMP production 
in gastric epithelium to secretin and VIP differs in 
man with that observed in dog and rat. 
It must be stressed that the VIP-sensitive cyclic 
AMP system of human gastric epithelium as well as 
the secretin-sensitive system of the other mammals 
studied [3,4] do not involve the parietal cell popula- 
tion, as suggested by: 
(1) 
(2) 
(3) 
The occurrence of a VIP-induced stimulation in 
fundus as well as in antrum; 
The lower magnitude of the VIP-induced stim- 
ulation in fundus; 
The additivity of the effects of histamine and 
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VIP in stimulating cyclic AMP production in 
fundus epithelial glands. 
Therefore, the VIP-sensitive cyclic AMP system is 
likely to operate in human mainly in pepsinogen- 
secreting cells and/or mucous cells as does secretin in 
dog [4] and rat (C.G. et al,, in preparation). 
The sensitivity to VIP of the cyclic AMP produc- 
tion in epithelial glands together with the important 
amounts of VIP present in the gastric wall strongly 
suggest hat, in human, VIP plays a physiological role 
in regulating the function of gastric epithelium. 
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